Madrigal Pharmaceuticals Inc MDGL
News
Madrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates
Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
Madrigal Pharmaceuticals to Release Second-Quarter 2024 Financial Results and Host Webcast on August 7, 2024
Madrigal's stock surges as FDA approves first drug for liver disease MASH
Madrigal Shares Leap Premarket on First FDA NASH Green Light
Madrigal Pharmaceuticals Wins Accelerated Approval for Rezdiffra From FDA
Madrigal Gets FDA Priority Review of Resmetirom in NASH With Liver Fibrosis
Tesla and Canopy Growth stocks surge, RTX and J.M. Smucker shares fall, and other stocks on the move
Madrigal Pharmaceuticals shares fall after new CEO named